BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Bausch Health Companies Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$6.32+0.02 (+0.32%)
Close on Oct 19, 2026
- Market cap
- $2.39B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
63.4%
237M of 374M shares
Institutional holders
220
29 new, 34 sold out
Net institutional buying
4M
In Q2 2026
Insider trades, 12 months
1 buys · 5 sales
Net bought $15.12M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Paulson & Co. Inc. | 70,755,869 | 19.10% | 13D (active) amendment | Aug 14, 2025 |
| Alex Meruelo | 36,761,788 | 9.99% | 13D (active) | Mar 31, 2025 |
| Steven A. Tananbaum | 35,243,712 | 9.50% | 13G (passive) amendment | Jun 30, 2025 |
| Icahn Capital LP | 34,721,118 | 9.40% | 13D (active) amendment | May 20, 2025 |
| Nomura Holdings Inc | 23,395,000 | 6.30% | 13G (passive) | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BHC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Paulson & Co. Inc. | 73,255,869 | 19.59% | $361.15M | – | 14.02% |
| Goldentree Asset Management LP | 34,665,731 | 9.27% | $170.71M | – | 9.92% |
| Royal Bank of Canada | 10,832,582 | 2.90% | $53.40M | −530,916 | 0.01% |
| Healthcare Of Ontario Pension Plan Trust Fund | 8,000,000 | 2.14% | $39.44M | – | 0.06% |
| Vanguard Capital Management LLC | 7,465,468 | 2.00% | $36.80M | +61,709 | 0.00% |
| Goldman Sachs Group Inc | 6,225,131 | 1.66% | $30.69M | +1,017,165 | 0.00% |
| MFN Partners Management, LP | 6,000,000 | 1.60% | $29.58M | – | 0.61% |
| SG Americas Securities, LLC | 5,535,771 | 1.48% | $27.29K | +5,520,961 | 0.02% |
| Acadian Asset Management LLC | 5,482,986 | 1.47% | $26.98K | +603,501 | 0.03% |
| Kohlberg Kravis Roberts & Co. L.P. | 5,235,000 | 1.40% | $25.81M | – | 0.45% |
| Ing Groep Nv | 5,000,000 | 1.34% | $24.65M | – | 0.12% |
| Hudson Bay Capital Management LP | 5,000,000 | 1.34% | $24.65M | – | 0.07% |
| Geode Capital Management, LLC | 4,803,485 | 1.28% | $33.17M | +574,614 | 0.00% |
| Gendell Jeffrey L | 4,037,091 | 1.08% | $19.90M | +1,067,251 | 0.18% |
| Norges Bank | 3,431,117 | 0.92% | $16.91M | New | 0.00% |
| Macquarie Group Ltd | 3,250,000 | 0.87% | $16.02M | – | 0.07% |
| Dimensional Fund Advisors LP | 3,241,140 | 0.87% | $15.98M | −363,678 | 0.00% |
| D. E. Shaw & Co., Inc. | 2,689,942 | 0.72% | $13.26M | +2,068,187 | 0.01% |
| Vanguard Fiduciary Trust Co | 2,250,910 | 0.60% | $11.09M | +29,745 | 0.00% |
| Point72 Asset Management, L.P. | 2,235,821 | 0.60% | $11.02M | +885,559 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 220 | 237M | 63.4% | 29 / 69 | 63 / 34 | 23M | 19M |
| Q1 2026 | 226 | 233M | 62.2% | 29 / 84 | 59 / 34 | 31M | 23M |
| Q4 2025 | 235 | 236M | 63.1% | 51 / 84 | 51 / 28 | 30M | 35M |
| Q3 2025 | 217 | 241M | 64.4% | 35 / 57 | 65 / 26 | 53M | 68M |
| Q2 2025 | 210 | 256M | 68.3% | 27 / 61 | 64 / 43 | 33M | 21M |
| Q1 2025 | 228 | 244M | 65.2% | 36 / 67 | 67 / 29 | 29M | 39M |
| Q4 2024 | 223 | 254M | 67.8% | 39 / 52 | 76 / 24 | 16M | 17M |
| Q3 2024 | 210 | 255M | 68.2% | 27 / 45 | 71 / 49 | 25M | 50M |
| Q2 2024 | 233 | 281M | 75.1% | 38 / 60 | 75 / 37 | 25M | 32M |
| Q1 2024 | 235 | 288M | 76.9% | 36 / 49 | 70 / 33 | 21M | 22M |
| Q4 2023 | 233 | 289M | 77.2% | 41 / 52 | 71 / 28 | 33M | 39M |
| Q3 2023 | 222 | 294M | 78.7% | 32 / 48 | 71 / 38 | 49M | 21M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of BHC | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total International Stock Index Fund | 3,762,192 | 1.01% | $36.31M | 0.00% | Jul 31, 2026 |
| Vanguard Developed Markets Index Fund | 2,481,313 | 0.66% | $17.34M | 0.00% | Jun 30, 2026 |
| Schwab Fundamental International Equity ETF | 1,414,010 | 0.38% | $5.52M | 0.03% | May 31, 2026 |
| Vanguard Ftse All-World Ex-US Small-Cap Index Fund | 986,066 | 0.26% | $9.52M | 0.05% | Jul 31, 2026 |
| The Canadian Small Company Series | 815,010 | 0.22% | $5.62M | 0.28% | Jul 31, 2026 |
| International Core Equity 2 Portfolio | 594,511 | 0.16% | $4.10M | 0.01% | Jul 31, 2026 |
| Schwab International Small-Cap Equity ETF | 542,712 | 0.15% | $2.12M | 0.05% | May 31, 2026 |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | 398,753 | 0.11% | $1.38M | 0.00% | Jun 30, 2026 |
| iShares Core MSCI Total International Stock ETF | 377,486 | 0.10% | $1.85M | 0.00% | Jul 31, 2026 |
| iShares Core MSCI International Developed Markets ETF | 358,322 | 0.10% | $1.76M | 0.01% | Jul 31, 2026 |
| Dimensional International Small Cap ETF | 332,180 | 0.09% | $2.29M | 0.04% | Jul 31, 2026 |
| Schwab Fundamental International Equity Index Fund | 287,988 | 0.08% | $1.41M | 0.04% | Jul 31, 2026 |
| Dimensional International Small Cap Value ETF | 214,485 | 0.06% | $1.48M | 0.03% | Jul 31, 2026 |
| Dimensional International Core Equity 2 ETF | 214,273 | 0.06% | $1.48M | 0.01% | Jul 31, 2026 |
| Voya Multi-Manager International Small Cap Fund | 192,793 | 0.05% | $946.71K | 0.23% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Thomas Appio | Chief Executive Officer, Director | 3,453,236 | 0.92% | Mar 3, 2026 |
| Aimee J. Lenar | President, US Pharma | 334,853 | 0.09% | Aug 20, 2026 |
| Steven Hyosig Lee | SVP, Controller & CAO | 70,114 | 0.02% | Jul 15, 2026 |
| Seana Carson | EVP, General Counsel | 616,761 | 0.16% | Mar 3, 2026 |
| Jean-Jacques Charhon | EVP, CFO | 706,478 | 0.19% | Mar 3, 2026 |
| John S. Barresi | SVP, Controller & CAO | 197,364 | 0.05% | Mar 3, 2025 |
| Sandra Leung | Director | 97,070 | 0.03% | Jul 2, 2026 |
| John Paulson | Director | 73,686,111 | 19.70% | Jul 2, 2026 |
| Amy B. Wechsler | Director | 314,979 | 0.08% | Jul 2, 2026 |
| Sarah B. Kavanagh | Director | 282,230 | 0.08% | May 26, 2026 |
| Robert N. Power | Director | 300,594 | 0.08% | May 26, 2026 |
| Christian A. Garcia | Director | 135,578 | 0.04% | May 26, 2026 |
| Eiry Roberts | Director | 45,871 | 0.01% | May 26, 2026 |
| Michael Goettler | Director | 76,020 | 0.02% | May 26, 2026 |
| Frank D. Lee | Director | 95,210 | 0.03% | May 26, 2026 |
| Brett Icahn | Director | 220,280 | 0.06% | Jul 2, 2025 |
| Steven D. Miller | Director | 239,224 | 0.06% | May 20, 2025 |
| Richard Mulligan | Director | 155,616 | 0.04% | May 20, 2025 |
| & Co. Inc. Paulson | 10% owner | 73,255,869 | 19.59% | Nov 28, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Aimee J. Lenar President, US Pharma | Aug 19, 2026 | Sale(10b5-1 plan) | −36,827 | $7.03 | $258.89K | 334,853 |
| Aimee J. Lenar President, US Pharma | Jul 17, 2026 | Tax withholding | −5,260 | $4.83 | $25.41K | 371,680 |
| Aimee J. Lenar President, US Pharma | Jul 15, 2026 | Tax withholding | −23,395 | $4.89 | $114.40K | 376,940 |
| Steven Hyosig Lee SVP, Controller & CAO | Jul 14, 2026 | Tax withholding | −3,125 | $4.75 | $14.84K | 70,114 |
| Amy B. Wechsler Director | Jun 30, 2026 | Award | +1,394 | $4.93 | $6.87K | 314,979 |
| Sandra Leung Director | Jun 30, 2026 | Award | +6,845 | $4.93 | $33.75K | 97,070 |
| John Paulson Director | Jun 30, 2026 | Award | +12,677 | $4.93 | $62.50K | 430,242 |
| Michael Goettler Director | May 22, 2026 | Award | +45,871 | – | – | 76,020 |
| Sandra Leung Director | May 22, 2026 | Award | +45,871 | – | – | 90,225 |
| Robert N. Power Director | May 22, 2026 | Award | +45,871 | – | – | 300,594 |
| John Paulson Director | May 22, 2026 | Award | +45,871 | – | – | 417,565 |
| Amy B. Wechsler Director | May 22, 2026 | Award | +45,871 | – | – | 313,585 |
| Frank D. Lee Director | May 22, 2026 | Award | +45,871 | – | – | 95,210 |
| Eiry Roberts Director | May 22, 2026 | Award | +45,871 | – | – | 45,871 |
| Christian A. Garcia Director | May 22, 2026 | Award | +45,871 | – | – | 135,578 |
| Sarah B. Kavanagh Director | May 22, 2026 | Award | +45,871 | – | – | 282,230 |
| Frank D. Lee Director | May 19, 2026 | Sale(10b5-1 plan) | −24,456 | $5.43 | $132.80K | 49,339 |
| Sandra Leung Director | Mar 31, 2026 | Award | +5,946 | $5.40 | $32.11K | 44,354 |
| Amy B. Wechsler Director | Mar 31, 2026 | Award | +1,273 | $5.40 | $6.87K | 267,714 |
| John Paulson Director | Mar 31, 2026 | Award | +11,574 | $5.40 | $62.50K | 371,694 |
| Seana Carson EVP, General Counsel | Mar 3, 2026 | Sale(10b5-1 plan) | −4,420 | $5.77 | $25.50K | 616,761 |
| Seana Carson EVP, General Counsel | Mar 2, 2026 | Other | −137,922 | $5.95 | $820.64K | 621,181 |
| Seana Carson EVP, General Counsel | Mar 2, 2026 | Tax withholding | −16,973 | $5.95 | $100.99K | 759,103 |
| Seana Carson EVP, General Counsel | Mar 2, 2026 | Sale(10b5-1 plan) | −6,856 | $5.78 | $39.63K | 776,076 |
| Thomas Appio Chief Executive Officer, Director | Mar 2, 2026 | Tax withholding | −83,705 | $5.95 | $498.04K | 3,453,236 |
| Thomas Appio Chief Executive Officer, Director | Mar 2, 2026 | Other | −1,137,862 | $5.95 | $6.77M | 2,315,374 |
| Seana Carson EVP, General Counsel | Feb 27, 2026 | Tax withholding | −26,326 | $5.93 | $156.11K | 782,932 |
| Thomas Appio Chief Executive Officer, Director | Feb 27, 2026 | Tax withholding | −83,093 | $5.93 | $492.74K | 3,536,941 |
| Jean-Jacques Charhon EVP, CFO | Feb 27, 2026 | Tax withholding | −49,060 | $5.93 | $290.93K | 706,478 |
| Seana Carson EVP, General Counsel | Feb 27, 2026 | Sale(10b5-1 plan) | −8,388 | $5.95 | $49.91K | 809,258 |
| Thomas Appio Chief Executive Officer, Director | Feb 26, 2026 | Tax withholding | −116,502 | $6.04 | $703.67K | 3,620,034 |
| Seana Carson EVP, General Counsel | Feb 26, 2026 | Tax withholding | −32,211 | $6.04 | $194.55K | 817,646 |
| Aimee J. Lenar EVP, US Pharma | Feb 26, 2026 | Tax withholding | −17,578 | $6.04 | $106.17K | 400,335 |
| Jean-Jacques Charhon EVP, CFO | Feb 26, 2026 | Tax withholding | −35,977 | $6.04 | $217.30K | 755,538 |
| Thomas Appio Chief Executive Officer, Director | Feb 25, 2026 | Award | +815,425 | – | – | 3,736,536 |
| Seana Carson EVP, General Counsel | Feb 25, 2026 | Award | +212,350 | – | – | 849,857 |
| Steven Hyosig Lee SVP, Controller & CAO | Feb 25, 2026 | Award | +45,868 | – | – | 73,239 |
| Aimee J. Lenar EVP, US Pharma | Feb 25, 2026 | Award | +157,139 | – | – | 417,913 |
| Jean-Jacques Charhon EVP, CFO | Feb 25, 2026 | Award | +276,055 | – | – | 791,515 |
| Thomas Appio Chief Executive Officer, Director | Feb 9, 2026 | Award | +1,137,862 | – | – | 2,921,111 |
| Seana Carson EVP, General Counsel | Feb 9, 2026 | Award | +137,922 | – | – | 637,507 |
| John Paulson Director | Dec 31, 2025 | Award | +8,992 | – | – | 360,120 |
| Sandra Leung Director | Dec 31, 2025 | Award | +4,586 | – | – | 38,408 |
| Amy B. Wechsler Director | Dec 31, 2025 | Award | +989 | – | – | 266,441 |
| & Co. Inc. Paulson 10% owner | Nov 25, 2025 | Buy | +2,500,000 | $6.25 | $15.63M | 73,255,869 |
| Amy B. Wechsler Director | Sep 30, 2025 | Award | +1,065 | – | – | 265,452 |
| Sandra Leung Director | Sep 30, 2025 | Award | +3,673 | – | – | 33,822 |
| John Paulson Director | Sep 30, 2025 | Award | +9,689 | – | – | 351,128 |
| Seana Carson EVP, General Counsel | Sep 8, 2025 | Sale(10b5-1 plan) | −13,370 | $7.31 | $97.73K | 499,585 |
| Seana Carson EVP, General Counsel | Sep 5, 2025 | Tax withholding | −51,337 | $7.35 | $377.33K | 512,955 |
| Frank D. Lee Director | Aug 21, 2025 | Sale | −15,912 | $7.66 | $121.89K | 73,795 |
| John Paulson Director | Aug 14, 2025 | Buy | +34,721,118 | $9.00 | $312.49M | 70,755,869 |
| John Paulson Director | Aug 13, 2025 | Buy | +86,409 | $7.06 | $610.05K | 36,034,751 |
| John Paulson Director | Aug 12, 2025 | Buy | +1,156,640 | $6.88 | $7.96M | 35,948,342 |
| John Paulson Director | Aug 11, 2025 | Buy | +2,000,000 | $6.35 | $12.70M | 34,791,702 |
| Michael Goettler Director | Jul 25, 2025 | Award | +30,149 | – | – | 30,149 |
| Sandra Leung Director | Jul 25, 2025 | Award | +30,149 | – | – | 30,149 |
| Aimee J. Lenar EVP, US Pharma | Jul 17, 2025 | Award | +30,847 | – | – | 260,774 |
| Aimee J. Lenar EVP, US Pharma | Jul 15, 2025 | Tax withholding | −22,736 | $6.42 | $145.97K | 229,927 |
| Steven Hyosig Lee SVP, Controller & CAO | Jul 14, 2025 | Award | +27,371 | – | – | 27,371 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Aimee J. Lenar Officer | Aug 19, 2026 | 36,827 | $258.89K | Aug 19, 2026 | Restricted Stock Vesting |
| Frank D. Lee Director | May 19, 2026 | 24,456 | $132.80K | May 19, 2026 | Restricted Stock Vesting |
| Seana Carson Officer | Mar 3, 2026 | 4,420 | $25.50K | Mar 3, 2026 | Restricted Stock Vesting |
| Seana Carson Officer | Mar 2, 2026 | 6,856 | $39.63K | Mar 2, 2026 | Restricted Stock Vesting |
| Seana Carson Officer | Feb 27, 2026 | 8,388 | $49.91K | Feb 27, 2026 | Restricted Stock Vesting |
| Seana Carson Officer | Sep 8, 2025 | 13,370 | $97.73K | Sep 8, 2025 | Restricted Stock Vesting |
| Frank D. Lee Director | Aug 21, 2025 | 15,912 | $121.89K | Aug 21, 2025 | Restricted Stock Vesting |
| Seana Carson Officer | Dec 2, 2024 | 440 | $3.67K | Dec 2, 2024 | Restricted Stock Vesting |
| Seana Carson Officer | Sep 6, 2024 | 13,370 | $83.03K | Sep 6, 2024 | Restricted Stock Vesting |
| Seana Carson Officer | Mar 4, 2024 | 6,313 | $61.87K | Mar 4, 2024 | Restricted Stock Vesting |
| Seana Carson Officer | Dec 5, 2023 | 220 | $1.62K | Dec 5, 2023 | Restricted Stock Vesting |
| Seana Carson Officer | Nov 6, 2023 | 43 | $327 | Nov 6, 2023 | Restricted Stock Vesting |
| Seana Carson Officer | Sep 6, 2023 | 6,685 | $55.35K | Sep 6, 2023 | Restricted Stock Vesting |